Warfarin — anticoagulant-related nephropathy


PRAC analyzed pooled data from spontaneous case reports, clinical trials, and the literature regarding the risk of anticoagulant-associated nephropathy in patients receiving warfarin. PRAC has agreed that MAH of drugs containing warfarin should submit a change within 2 months of publication of the PRAC recommendation to change the product information - where applicable, the proposed [...]